Modulation of neuronal activity by the endogenous pentapeptide QYNAD

European Journal of Neuroscience

Volumn 18, Issue 10, 2003, Pages 2697-2706

  Meuth, Sven G ^a   Budde, Thomas ^a   Duyar, Hüseyin ^b   Landgraf, Peter ^a   Broicher, Tilman ^a   Elbs, Martin ^b   Brock, Roland ^b   Weller, Michael ^b   Weissert, Robert ^b   Wiendl, Heinz ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Axonal dysfunction; Endogenous pentapeptide; Multiple sclerosis; QYNAD

Indexed keywords

ANTIBODY; CYTOKINE; GLUTAMINYLTYROSYLASPARAGINYLALANYLASPARTIC ACID; NITRIC OXIDE; PENTAPEPTIDE; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMYELINATION; FEMALE; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NERVE FIBER; NERVE POTENTIAL; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; STEADY STATE; THALAMUS;

ANESTHETICS, LOCAL; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FEMALE; GENICULATE BODIES; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MEMBRANE POTENTIALS; NEURAL CONDUCTION; NEURONS; OLIGOPEPTIDES; RATS; RATS, INBRED STRAINS; RATS, LONG-EVANS; SODIUM CHANNELS; TETRODOTOXIN; TIME FACTORS;

EID: 10744227950     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2003.02985.x     Document Type: Article

References (33)

1. Alcazar, A., Regidor, I., Masjuan, J., Salinas, M. & Alvarez-Cermeno, J.C. (2000) Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis. J. Neuroimmunol., 104, 58-67.
2. Balser, J.R., Nuss, H.B., Orias, D.W., Johns, D.C., Marban, E., Tomaselli, G.F. & Lawrence, J.H. (1996) Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels. J. Clin. Invest., 98, 2874-2886.
3. + channel blocker QYNAD determined in CSF and serum of GBS patients using ion trap spectroscopy. Eur. J. Neurosci., 55, 365.
4. Brinkmeier, H., Aulkemeyer, P., Wollinsky, K.H. & Rüdel, R. (2000) An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nature Med., 6, 808-811.
5. Brinkmeier, H., Wollinsky, K.H., Seewald, M.J., Hulser, P.J., Mehrkens, H.H., Kornhuber, H.H. & Rüdel, R. (1993) Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channels. Neurosci. Lett., 156, 172-175.
6. Butterworth, J.F.T. & Strichartz, G.R. (1990) Molecular mechanisms of local anesthesia: a review. Anesthesiology, 72, 711-734.
7. Cantrell, A.R. & Catterall, W.A. (2001) Neuromodulation of Na+ channels: an unexpected form of cellular plasticity. Nature Rev. Neurosci., 2, 397-407.
8. Catterall, W.A. (1992) Cellular and molecular biology of voltage-gated sodium channels. Physiol. Rev., 72, S15-S48.
9. Courtney, K.R. (1975) Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J. Pharmacol. Exp. Ther., 195, 225-236.
10. Cummins, T.R., Renganathan, M., Stys, P.K., Herzog, R.I., Scarfo, K., Horn, R., Dib-Hajj, S.D. & Waxman, S.G. (2003) The pentapeptide QYNAD does not block voltage-gated sodium channels. Neurology, 60, 224-229.
11. Diem, R., Tschirne, A. & Bähr, M. (2003) Decreased amplitudes in multiple sclerosis patients with normal visual acuity: a VEP study. J. Clin. Neurosci., 10, 67-70.
12. + channels. J. Exp. Biol., 205, 575-584.
13. + channel α-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J. Comp. Neurol., 412, 342-352.
14. Hamill, O.P., Marty, A., Neher, E., Sakmann, B. & Sigworth, F.J. (1981) Improved patch-clamp technique for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
15. Kapoor, R., Davies, M., Blaker, P.A., Hall, S.M. & Smith, K.J. (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol., 53, 174-180.
16. + current. Brain, 119, 457-463.
17. Kornek, B., Storch, M.K., Bauer, J., Djamshidian, A., Weissert, R., Wallstroem, E., Stefferl, A., Zimprich, F., Olsson, T., Linington, C., Schmidbauer, M. & Lassmann, H. (2001) Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain, 124, 1114-1124.
18. Lo, A.C., Black, J.A. & Waxman, S.G. (2002) Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport, 13, 1909-1912.
19. Magistretti, J. & Alonso, A. (1999) Biophysical properties and slow voltage-dependent inactivation of a sustained sodium current in entorhinal cortex layer-II principal neurons: a whole-cell and single-channel study. J. General Physiol., 114, 491-509.
20. 2+-dependent inactivation mechanism in thalamic relay neurons. Thalamus Related Systems, 1, 31-38.
21. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. & Weinshenker, B.G. (2000) Multiple sclerosis. N. Engl. J. Med., 343, 938-952.
22. Nuss, H.B., Kambouris, N.G., Marban, E., Tomaselli, G.F. & Balser, J.R. (2000) Isoform-specific lidocaine block of sodium channels explained by differences in gating. Biophys. J., 78, 200-210.
23. Nuss, H.B., Tomaselli, G.F. & Marban, E. (1995) Cardiac sodium channels (hHl) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (μl) channels. J. General Physiol., 106, 1193-1209.
24. Parri, H.R. & Crunelli, V. (1998) Sodium current in rat and cat thalamocortical neurons: role of a non-inactivating component in tonic and burst firing. J. Neurosci., 18, 854-867.
25. Sakurai, M., Mannen, T., Kanazawa, I. & Tanabe, H. (1992) Lidocaine unmasks silent demyelinative lesions in multiple sclerosis. Neurology, 42, 2088-2093.
26. Smith, K.J. & Hall, S.M. (2001) Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding. Curr. Opin. Neurol., 14, 289-298.
27. Smith, K.J., Kapoor, R., Hall, S.M. & Davies, M. (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol., 49, 470-476.
28. Trapp, B.D., Ransohoff, R. & Rudick, R. (1999) Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol., 12, 295-302.
29. Tumani, H.P., Aulkemeyer, S., Süssmuth, R., Rüdel, R. & Brinkmeier, H. (2001) Das endogene Natrium-Kanal-blockierende Pentapeptid Gln-Tyr-Asn-Ala-Asp (QYNAD) bei multipler Sklerose: erhöhte Liquorkonzentration korreliert nicht mit klinischer Beeinträchtigung oder MRT-Läsionen. Aktuelle Neurologie, 28, 493.
30. Waxman, S.G. (2000) Do 'demyelinating' diseases involve more than myelin? Nature Med., 6, 738-739.
31. Weber, F., Rüdel, R., Aulkemeyer, P. & Brinkmeier, H. (2002) The endogenous pentapeptide QYNAD induces acute conduction block in the isolated rat sciatic nerve. Neurosci. Lett., 317, 33-36.
32. Weissert, R., Wallstrom, E., Storch, M.K., Stefferl, A., Lorentzen, J., Lassmann, H., Linington, C. & Olsson, T. (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest., 102, 1265-1273.
33. 2+ current produces input signal amplification and bistability in cat and rat thalamocortical neurones. J. Physiol. (Lond.), 505, 689-705.